Amalgamated Financial’s Mesa Laboratories MLAB Stock Holding History

Amalgamated Financial’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$591K	Buy	+2,317	New	+$629K	﹤0.01%	1445

Other funds holding MLAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Amalgamated Financial's MLAB Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Mesa Laboratories (MLAB) in Q1 2022: 2,317 shares worth $591K. The stake represents ﹤0.01% of the portfolio and ranks #1445 among its holdings.

175 funds tracked by Wall St. Rank hold MLAB as of Q1 2022.

Amalgamated Financial held 2,317 shares of Mesa Laboratories worth $591K as of Q1 2022.
Mesa Laboratories was a new Amalgamated Financial position in Q1 2022.
Mesa Laboratories made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1445 holding.
175 funds tracked by Wall St. Rank held Mesa Laboratories as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.